Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of68Ga3 +,111In3 +,177Lu3 +and225Ac3 + Academic Article uri icon

Overview

MeSH Major

  • Amyloidosis
  • Brain
  • Cognition Disorders
  • Diabetes Mellitus, Type 2

abstract

  • The broad metal ion selectivity, good in vitro affinity for PSMA and good in vivo tumor targeting suggest that EuK-107, with the 3p-C-DEPA chelator, merits further evaluation as a theranostics construct in prostate cancer.

publication date

  • December 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.nucmedbio.2017.10.001

PubMed ID

  • 29055836

Additional Document Info

start page

  • 38

end page

  • 46

volume

  • 55